Hepatitis/MASH

The Pharmacy Times® Hepatitis Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of a group of distinct diseases that cause inflammation of the liver, including hepatitis A, B, C, and D.

Latest News

Liver pain: abdominal discomfort, hepatic strain, organ distress, bile issue, jaundice symptom, inflammation, detox failure, cirrhosis sign, liver infection, digestive disturbance.
Remnant Cholesterol, Independent of LDL-C, Serves as Predictor of MASLD

July 24th 2025

High levels of remnant cholesterol were associated with increased risk of developing metabolic dysfunction-associated steatotic liver disease (MASLD) independent of low-density lipoprotein cholesterol (LDL-C).

DNA structure and HIV-infected
IAS 2025: Patients With HIV Grapple With Healthy Aging, Reducing CVD Risk

July 21st 2025

A Novel Agent, Incretin Mimetics, and Potential Pharmacologicals for the Management of MASH
A Novel Agent, Incretin Mimetics, and Potential Pharmacologicals for the Management of MASH

July 18th 2025

Hepatocellular Carcinoma Cells: These liver cells, or hepatocytes, can develop into tumors in the liver, often associated with cirrhosis or chronic liver disease. - Image credit: Best | stock.adobe.com
FDA Approves Y-90 Resin Microspheres for Unresectable Hepatocellular Carcinoma

July 7th 2025

Hepatitis C virus model, 3D illustration. A virus consists of a protein coat, capsid, surrounding RNA and outer lipoprotein envelope with 2 types of glycoprotein spikes, E1 and E. - Image credit: Dr_Microbe | stock.adobe.com
Glecaprevir/Pibrentasvir Combination Receives FDA Approval Expanded Indication for Acute HCV

June 11th 2025

<1
...
3637383940